Bridgefront Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,168
| Closed | -$182K | – | 857 |
|
|
2025
Q1 | $182K | Buy |
+10,168
| New | +$182K | 0.05% | 534 |
|
|
2024
Q4 | – | Sell |
-17,688
| Closed | -$247K | – | 788 |
|
|
2024
Q3 | $247K | Buy |
17,688
+7,623
| +76% | +$107K | 0.1% | 390 |
|
|
2024
Q2 | $82.7K | Buy |
+10,065
| New | +$82.7K | 0.03% | 454 |
|
|
2024
Q1 | – | Sell |
-10,329
| Closed | -$92.9K | – | 558 |
|
|
2023
Q4 | $92.9K | Buy |
+10,329
| New | +$92.9K | 0.07% | 341 |
|